Primary |
Migraine |
40.0% |
Headache |
20.4% |
Pain |
9.1% |
Back Pain |
4.6% |
Arthritis |
3.9% |
Off Label Use |
3.9% |
Fibromyalgia |
2.8% |
Tension Headache |
2.5% |
Diabetes Mellitus |
1.8% |
Psychiatric Symptom |
1.8% |
Arthralgia |
1.4% |
Hypertension |
1.4% |
Sinus Headache |
1.4% |
Ulcer |
1.1% |
Anxiety |
0.7% |
Convulsion |
0.7% |
Epilepsy |
0.7% |
Gastrooesophageal Reflux Disease |
0.7% |
Heat Stroke |
0.7% |
Hypersensitivity |
0.7% |
|
Overdose |
14.7% |
Underdose |
14.7% |
Vomiting |
12.6% |
Therapeutic Response Unexpected |
10.5% |
Off Label Use |
7.4% |
Death |
3.2% |
Feeling Abnormal |
3.2% |
Hypertension |
3.2% |
Incorrect Dose Administered |
3.2% |
Thrombosis |
3.2% |
Visual Impairment |
3.2% |
Withdrawal Syndrome |
3.2% |
Wrong Technique In Drug Usage Process |
3.2% |
Diabetes Mellitus |
2.1% |
Gastric Disorder |
2.1% |
Headache |
2.1% |
Pain |
2.1% |
Pruritus |
2.1% |
Skull Fracture |
2.1% |
Swelling |
2.1% |
|
Secondary |
Headache |
22.7% |
Migraine |
22.5% |
Off Label Use |
10.4% |
Pain |
7.9% |
Foetal Exposure During Pregnancy |
6.8% |
Back Pain |
6.1% |
Diabetes Mellitus |
2.7% |
Hypersensitivity |
2.3% |
Lymphadenopathy |
2.3% |
Neck Pain |
2.1% |
Fibromyalgia |
1.7% |
Insomnia |
1.7% |
Asthma |
1.5% |
Product Used For Unknown Indication |
1.5% |
Hypertension |
1.4% |
Myalgia |
1.4% |
Sinus Headache |
1.4% |
Dysstasia |
1.2% |
Muscle Spasms |
1.2% |
Supplementation Therapy |
1.2% |
|
Therapeutic Response Unexpected |
18.1% |
Underdose |
16.0% |
Weight Decreased |
8.5% |
Off Label Use |
7.4% |
Incorrect Dose Administered |
4.3% |
Overdose |
4.3% |
Premature Baby |
4.3% |
Thrombosis |
4.3% |
Urticaria |
4.3% |
Cerebrovascular Accident |
3.2% |
Drug Ineffective |
3.2% |
Neck Pain |
3.2% |
Tendonitis |
3.2% |
Vomiting |
3.2% |
Disease Recurrence |
2.1% |
Feeling Abnormal |
2.1% |
Headache |
2.1% |
Hypertension |
2.1% |
Migraine |
2.1% |
Musculoskeletal Pain |
2.1% |
|
Concomitant |
Product Used For Unknown Indication |
32.7% |
Migraine |
14.5% |
Headache |
11.2% |
Contraception |
5.1% |
Pain |
4.4% |
Anxiety |
3.5% |
Bipolar Disorder |
3.0% |
Crohn's Disease |
3.0% |
Gastrooesophageal Reflux Disease |
2.8% |
Depression |
2.3% |
Nausea |
2.3% |
Psoriasis |
2.1% |
Acne |
1.9% |
Prophylaxis |
1.9% |
Multiple Sclerosis |
1.6% |
Rheumatoid Arthritis |
1.6% |
Sleep Disorder |
1.6% |
Hypersensitivity |
1.4% |
Musculoskeletal Stiffness |
1.4% |
Psoriatic Arthropathy |
1.4% |
|
Drug Ineffective |
18.3% |
Pulmonary Embolism |
13.3% |
Vomiting |
10.0% |
Pain |
6.7% |
Thrombosis |
6.7% |
Psychological Trauma |
5.0% |
Headache |
3.3% |
Injection Site Pain |
3.3% |
Overdose |
3.3% |
Photophobia |
3.3% |
Pulmonary Infarction |
3.3% |
Rash |
3.3% |
Transverse Sinus Thrombosis |
3.3% |
Vertigo |
3.3% |
Vision Blurred |
3.3% |
White Blood Cell Count Decreased |
3.3% |
Atrial Fibrillation |
1.7% |
Cerebral Venous Thrombosis |
1.7% |
Cholecystitis Chronic |
1.7% |
Colitis |
1.7% |
|